Cargando…
High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis
To test the carcinostatic effects of ascorbic acid, we challenged the mice of seven experimental groups with 1.7 × 10(-4 )mol high dose concentration ascorbic acid after intraperitoneal administrating them with sarcoma S-180 cells. The survival rate was increased by 20% in the group that received hi...
Autores principales: | Yeom, Chang-Hwan, Lee, Gunsup, Park, Jin-Hee, Yu, Jaelim, Park, Seyeon, Yi, Sang-Yeop, Lee, Hye Ree, Hong, Young Seon, Yang, Joosung, Lee, Sukchan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732919/ https://www.ncbi.nlm.nih.gov/pubmed/19671184 http://dx.doi.org/10.1186/1479-5876-7-70 |
Ejemplares similares
-
Proteomic analysis of tumor tissue in CT-26 implanted BALB/C mouse after treatment with ascorbic acid
por: Lee, Jihye, et al.
Publicado: (2011) -
A Nucleic-Acid Hydrolyzing Single Chain Antibody Confers Resistance to DNA Virus Infection in HeLa Cells and C57BL/6 Mice
por: Lee, Gunsup, et al.
Publicado: (2014) -
Antitumor activities of Juemingzi (Cassia tora L.) on Balb/c sarcoma 180-injected mice
por: CHEN, SHAOCHENG, et al.
Publicado: (2014) -
Hormetic dose response to (L)-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression
por: Cho, Sungrae, et al.
Publicado: (2018) -
The effect of pentoxifylline on L-1 sarcoma tumor growth and angiogenesis in Balb/c mice
por: Bałan, Barbara Joanna, et al.
Publicado: (2017)